Single-dose administration study of adrenomedullin

Phase 1 trial of adrenomedullin; Single-dose administration study

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080224808

Enrollment

Registered

2019-07-29

Start date

2015-11-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy

Interventions

investigational material(s) Generic name etc : adrenomedullin INN of investigational material : adrenomedullin Therapeutic category code : 249 Other hormone preparations (including antihormone prepara

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: healthy male

Exclusion criteria

Exclusion criteria: history of malignancy and/or myocardial infarction systolic blood pressure under 100 mmHg pulse rate under 45 bpm body weight over 90 kg

Design outcomes

Primary

Measure	Time frame
safety Safety and tolerability	—

Secondary

Measure	Time frame
pharmacokinetics pharmacokinetics	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026